We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · January 23, 2022

CHIP in Patients With Aggressive Lymphomas on CAR-T-Cell Treatment

Blood Advances

 

Additional Info

Blood Advances
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR-T-cell treatment
Blood Adv 2022 Jan 10;[EPub Ahead of Print], R Teipel, FP Kroschinsky, M Kramer, T Kretschmann, K Egger-Heidrich, T Krüger, L Ruhnke, S Herold, S Stasik, K Sockel, JM Middeke, K Trautmann-Grill, M Bornhauser, C Thiede, M von Bonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading